drug protocol number

17237

drug sponsor

Bayer

drug study

Rivaroxaban

drug trial site

King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah)

drug status

Ongoing

drug phase